1. Home
  2. PLSE vs BBAI Comparison

PLSE vs BBAI Comparison

Compare PLSE & BBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • BBAI
  • Stock Information
  • Founded
  • PLSE 2014
  • BBAI 2020
  • Country
  • PLSE United States
  • BBAI United States
  • Employees
  • PLSE N/A
  • BBAI N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • BBAI EDP Services
  • Sector
  • PLSE Health Care
  • BBAI Technology
  • Exchange
  • PLSE Nasdaq
  • BBAI Nasdaq
  • Market Cap
  • PLSE 1.1B
  • BBAI 1.1B
  • IPO Year
  • PLSE 2016
  • BBAI N/A
  • Fundamental
  • Price
  • PLSE $18.72
  • BBAI $4.44
  • Analyst Decision
  • PLSE
  • BBAI Buy
  • Analyst Count
  • PLSE 0
  • BBAI 4
  • Target Price
  • PLSE N/A
  • BBAI $4.50
  • AVG Volume (30 Days)
  • PLSE 129.0K
  • BBAI 47.2M
  • Earning Date
  • PLSE 10-30-2024
  • BBAI 03-06-2025
  • Dividend Yield
  • PLSE N/A
  • BBAI N/A
  • EPS Growth
  • PLSE N/A
  • BBAI N/A
  • EPS
  • PLSE N/A
  • BBAI N/A
  • Revenue
  • PLSE N/A
  • BBAI $154,972,000.00
  • Revenue This Year
  • PLSE N/A
  • BBAI $13.47
  • Revenue Next Year
  • PLSE N/A
  • BBAI $16.32
  • P/E Ratio
  • PLSE N/A
  • BBAI N/A
  • Revenue Growth
  • PLSE N/A
  • BBAI 0.01
  • 52 Week Low
  • PLSE $6.60
  • BBAI $1.17
  • 52 Week High
  • PLSE $22.69
  • BBAI $5.20
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 52.77
  • BBAI 60.06
  • Support Level
  • PLSE $17.18
  • BBAI $2.85
  • Resistance Level
  • PLSE $18.72
  • BBAI $4.79
  • Average True Range (ATR)
  • PLSE 1.10
  • BBAI 0.50
  • MACD
  • PLSE 0.06
  • BBAI 0.01
  • Stochastic Oscillator
  • PLSE 51.28
  • BBAI 67.45

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About BBAI BigBear.ai Inc.

BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment.

Share on Social Networks: